• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

The Effects of the Attributable Fraction and the Duration of Symptoms on Burden Estimates of Influenza-Associated Respiratory Illnesses in a High HIV-

tetano

Editor, Senior Moderator
Influenza Other Respir Viruses. 2017 Dec 6. doi: 10.1111/irv.12529. [Epub ahead of print]
[h=1]The Effects of the Attributable Fraction and the Duration of Symptoms on Burden Estimates of Influenza-Associated Respiratory Illnesses in a High HIV-Prevalence Setting, South Africa, 2013-2015.[/h] Tempia S[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Walaza S[SUP]3,[/SUP][SUP]4[/SUP], Moyes J[SUP]3,[/SUP][SUP]4[/SUP], Cohen AL[SUP]1,[/SUP][SUP]5[/SUP], von Mollendorf C[SUP]3,[/SUP][SUP]4[/SUP], McMorrow ML[SUP]1,[/SUP][SUP]2[/SUP], Mhlanga S[SUP]3[/SUP], Treurnicht FK[SUP]3[/SUP], Venter M[SUP]6[/SUP], Pretorius M[SUP]3,[/SUP][SUP]6,[/SUP][SUP]7[/SUP], Hellferscee O[SUP]3,[/SUP][SUP]8[/SUP], Wolter N[SUP]3,[/SUP][SUP]8[/SUP], von Gottberg A[SUP]3,[/SUP][SUP]8[/SUP], Nguweneza A[SUP]3[/SUP], McAnerney JM[SUP]3[/SUP], Dawood H[SUP]9,[/SUP][SUP]10[/SUP], Variava E[SUP]11,[/SUP][SUP]12,[/SUP][SUP]13[/SUP], Madhi SA[SUP]3,[/SUP][SUP]14,[/SUP][SUP]15[/SUP], Cohen C[SUP]3,[/SUP][SUP]4[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] The attributable fraction of influenza virus detection to illness (INF-AF) and the duration of symptoms as a surveillance inclusion criterion could potentially have substantial effects on influenza disease burden estimates.
[h=4]METHODS:[/h] We estimated rates of influenza-associated influenza-like illness (ILI) and severe acute (SARI-10) or chronic (SCRI-10) respiratory illness (using a symptom duration cut-off of ≤10 days) among HIV-infected and HIV-uninfected patients attending 3 hospitals and 2 affiliated clinics in South Africa during 2013-2015. We calculated the unadjusted and INF-AF adjusted rates and relative risk (RR) due to HIV infection. Rates were expressed per 100 000 population.
[h=4]RESULTS:[/h] The estimated mean annual unadjusted rates of influenza-associated illness were 1467.7, 50.3 and 27.4 among patients with ILI, SARI-10 and SCRI-10, respectively. After adjusting for the INF-AF the percent reduction of the estimated rates was 8.9% (rate: 1336.9), 11.0% (rate: 44.8) and 16.3% (rate: 22.9) among patients with ILI, SARI-10 and SCRI-10, respectively. HIV-infected compared to HIV-uninfected individuals experienced a 2.3 (95% CI: 2.2-2.4), 9.7 (95% CI: 8.0-11.8) and 10.0 (95% CI: 7.9-12.7) fold increased risk of influenza-associated illness among patients with ILI, SARI-10 and SCRI-10, respectively. Overall 34% of the estimated influenza-associated hospitalizations had symptom duration of >10 days; 8% and 44% among individuals aged <5 and ≥5 years, respectively.
[h=4]CONCLUSION:[/h] The marginal differences between unadjusted and INF-AF adjusted rates are unlikely to affect policies on prioritization of interventions. HIV-infected individuals experienced an increased risk of influenza-associated illness and may benefit more from annual influenza immunization. The use of a symptom duration cut-off of ≤10 days may underestimate influenza-associated disease burden, especially in older individuals. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.


[h=4]KEYWORDS:[/h] HIV ; Attributable Fraction; Influenza; Influenza-Like Illness; Rates; Severe Respiratory Illness; South Africa; Symptom Duration

PMID: 29210203 DOI: 10.1111/irv.12529
Free full text
 
Back
Top Bottom